Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sarepta Therapeutics, Inc. | Director | Common Stock | 27.8K | $2.77M | $99.64 | Mar 12, 2025 | Direct |
CASSAVA SCIENCES INC | Director | Stock Option (Right to Buy) | 26.5K | $169K | $16.87 | May 23, 2025 | Direct |
Gain Therapeutics, Inc. | Director | Stock Option (right to buy) | 15K | $87.9K | $5.86 | Jun 24, 2025 | Direct |
Chemomab Therapeutics Ltd. | Director | Option to Purchase American Depositary Shares | 11.9K | Mar 16, 2023 | Direct | ||
Sarepta Therapeutics, Inc. | Director | Stock Options (right to buy) | 0 | Mar 12, 2025 | Direct |